Study examines barriers to human papillomavirus vaccination among teens

November 25, 2013

Barriers to human papillomavirus (HPV) vaccination among adolescents in the U.S. range from financial concerns and parental attitudes to social influences and concerns about the vaccination's effect on sexual behavior, according to a review of the available medical literature published by JAMA Pediatrics.

HPV vaccine coverage among teenagers has increased since the vaccine was licensed in 2006 but it still remains low compared with other recommended vaccinations. Most HPV infections will clear on their own, but persistent infections can progress to precancers or cancers, including cervical, vulvar, vaginal, penile and anal cancer, as well as cancers of the mouth and throat. Vaccination is recommended for both girls and boys, based on age requirements for the specific vaccines, according to the study background.

Dawn M. Holman, M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and colleagues conducted a review of the literature on barriers to HPV vaccination. Their findings summarize 55 relevant articles, which include data collected in 2009 or later:

  • Healthcare professionals cited financial concerns and parental attitudes and concerns as barriers to providing the vaccine to patients.
  • Parents often reported barriers that included needing more information before vaccinating their children, as well as concerns about the vaccine's effect on , the low perceived risk of HPV infection, , irregular preventive care and vaccine costs.
  • Some parents of boys reported a perceived lack of benefit for vaccinating their sons.
  • Recommendations from were consistently reported by parents as one of the most important factors in their decision to vaccinate their children.

"Continued efforts are needed to ensure that health care professionals and parents understand the importance of vaccinating adolescents before they become sexually active. Health care professionals may benefit from guidance on communicating HPV recommendations to patients and parents," the study concludes.

Explore further: Misconceptions about HPV vaccine explored in special issue of scientific journal

More information: JAMA Pediatr. Published online November 25, 2013. DOI: 10.1001/jamapediatrics.2013.2752

Related Stories

Misconceptions about HPV vaccine explored in special issue of scientific journal

October 17, 2013
Suspicions about sexual promiscuity and vaccine safety are explored in an article in the November issue of the journal Preventive Medicine, which dedicates a section of that issue to research concerning the human papillomavirus.

Parental perceptions are preventing HPV vaccination success

October 21, 2013
A Mayo Clinic physician and two other pediatric experts say that parental perceptions pose a major barrier to acceptance of human papillomavirus (HPV) vaccination—and that many of those perceptions are wrong. Their comments ...

Vaccinating boys plays key role in HPV prevention

July 22, 2013
Improving vaccination rates against the human papillomavirus (HPV) in boys is key to protecting both men and women, says new research from University of Toronto Professor Peter A. Newman from the Factor-Inwentash Faculty ...

Study highlights attitudes toward HPV vaccination for boys

January 29, 2013
(Boston)- A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents/guardians were receptive toward vaccinating boys against Human Papilloma Virus (HPV). However, racial/ethnic ...

Cultural differences may explain why some don't get HPV vaccines

October 14, 2013
A new study explores why girls in minority groups and low-income families, who are most at risk for cervical cancer, may not be getting the human papillomavirus or HPV vaccine.

New study explores providers' perceptions of parental concerns about HPV vaccination

May 14, 2013
A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus (HPV), while white, middle-class parents ...

Recommended for you

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.